双色真藓的组织培养和发育研究

对双色真藓(Bryum dichotomum Hedw.)的孢子发育过程及愈伤组织的诱导和培养进行了研究。结果表明,双色真藓孢子萌发和原丝体发育属于典型的真藓型。将双色真藓原丝体接种在含有2.0 mg L-1的硅酸钠和3.0 mg L-1 6-BA的MS固体培养基上,可诱导双色真藓原丝体分化为愈伤组织。愈伤组织在含有2.0 mg L-1的硅酸钠、1.0 mg L-12,4-D和1.0 mg L-1 6-BA的MS固体培养基上可以长期继代培养。而愈伤组织在含有2.0 mg L-1的硅酸钠、1.0 mg L-1 2,4-D和1.0 mg L-1 6-BA的MS液体培养基中可以悬浮培养,且生长迅速,培养28 d达到接种鲜重的9.25倍。     

Platinum(II) oxalato complexes with adenine-based carrier ligands showing significant in vitro antitumor activity

[Pt(L)₂(ox)] (1), [Pt(2-OMeL)₂(ox)] (2), [Pt(3-OMeL)₂(ox)] (3), [Pt(2,3-diOMeL)₂(ox)] (4), [Pt(2,4-diOMeL)₂(ox)] (5), [Pt(3,4-diOMeL)₂(ox)] (6) and [Pt(3,5-diOMeL)₂(ox)]·4H₂O (7) platinum(II) oxalato (ox) complexes were synthesized using the reaction of potassium bis(oxalato)platinate(II) dihydrate with 2-chloro-N6-(benzyl)-9-isopropyladenine or its benzyl-substituted analogues (nL). The complexes 1-7, which represent the first platinum(II) oxalato complexes involving adenine-based ligands, were fully characterized by various physical methods including multinuclear and two dimensional NMR spectroscopy. A single-crystal X-ray analysis of [Pt(2,4-diOMeL)₂(ox)]·2DMF (5·2DMF; DMF = N,N′-dimethylformamide), proved the slightly distorted square-planar geometry in the vicinity of the Pt(II) ion with one bidentate-coordinated oxalate dianion and two adenine derivatives (nL) coordinated to the Pt(II) centre through the N7 atom of an adenine moiety, thereby giving a PtN₂O₂ donor set. In vitro cytotoxicity of the prepared complexes was tested by an MTT assay against osteosarcoma (HOS) and breast adenocarcinoma (MCF7) human cancer cell lines. The best results were achieved for the complexes 2 and 5 in the case of both cell lines, whose IC₅₀ values equalled 3.6 ± 1.0, and 4.3 ± 2.1 μM (for 2), and 5.4 ± 3.8, and 3.6 ± 2.1 μM (for 5), respectively. The IC₅₀ equals 9.2 ± 1.5 μM against MCF7 cells in the case of 1. The in vitro cytotoxicity of the mentioned complexes significantly exceeded commercially used platinum-based anticancer drugs cisplatin (34.2 ± 6.4 μM and 19.6 ± 4.3 μM) and oxaliplatin (> 50.0 μM for both cancer cell lines).     

Synthesis, characterization and in vitro cytotoxicity studies of platinum(IV) complexes with thiouracil ligands

Reactions of [PtMe₃(bpy)(Me₂CO)][BF₄] (2) with the thionucleobases 2-thiouracil (s²Ura), 4-thiouracil (s⁴Ura) and 2,4-dithiouracil (s²s⁴Ura) resulted in the formation of complexes of the type [PtMe₃(bpy)(L-κS)][BF₄] (L = s²Ura, 3; s⁴Ura, 4; s²s⁴Ura, 5). The complexes were characterized by NMR spectroscopy (¹H, ¹³C, ¹⁹⁵Pt), IR spectroscopy as well as microanalyses. The coordination through the C4S groups (4, 5) was additionally confirmed by DFT calculations, where it was shown that these complexes [PtMe₃(bpy)(L-κS⁴)]⁺ (L = s⁴Ura, s²s⁴Ura) are about 5.8 (4b) and 3.3 kcal/mol (5b), respectively, more stable than the respective complexes, having thiouracil ligands bound through the C2X groups (X = O, 4a; S, 5a). For [PtMe₃(bpy)(s²Ura-κS²)][BF₄] (3) no preferred coordination mode could be assigned solely based on DFT calculations. Analysis of NMR spectra showed the κS² coordination. In vitro cytotoxic studies of complexes 3−5 on nine different cell lines (8505C, A253, FaDu, A431, A549, A2780, DLD-1, HCT-8, HT-29) revealed in most cases moderate activities. However, 3 and 5 showed significant activity towards A549 and A2780, respectively, possessing IC₅₀ values comparable to those of cisplatin. Cell cycle perturbations and trypan blue exclusion test on cancer cell line A431 using [PtMe₃(bpy)(s²s⁴Ura-κS⁴)][BF₄] (5) showed induction of apoptotic cell death. Furthermore, the reaction of [PtMe₃(OAc-κ²O,O′)(Me₂CO)] (6) with 4-thiouracil yielded the dinuclear complex [(PtMe₃)₂(μ-s⁴Ura_-H)₂] (7), which has been characterized by microanalysis, NMR (¹H, ¹³C, ¹⁹⁵Pt) and IR spectroscopy as well as ESI mass spectrometry. X-ray diffraction analysis of crystals yielded in an isolated case exhibited the presence of a hexanuclear thiouracilato platinum(IV) complex, possessing each three different kinds of methyl platinum(IV) moieties and 4-thiouracilato ligands. This exhibited the ability of 4-thiouracil platinum(IV) complexes to form multinuclear complexes.     

Systematic synthesis, structural characterization, and reactivity studies of vanadium(V)–citrate anions [VO2(C6H6O7)]2, isolated from aqueous solutions in the presence of different cations

The aqueous chemistry of vanadium with physiologically relevant ligands constitutes a subject of burgeoning research, extending from bacterial metalloenzymic functions to human-health physiology. Vanadium, in the form of VCl₃ and V₂O_5, reacted expediently with citric acid, in a 1:2 molar ratio in water at pH4, and, in the presence of various cations, afforded crystalline materials bearing the general formula (Cat)₂[V₂O₄(C₆H₆O₇)₂]·nH₂O (A) (Cat⁺=Na⁺, NH₄ ⁺, n=2; Me₄N⁺, K⁺, n=4). Exploration of the reactivity of A toward H₂O₂ yielded the peroxo-containing complexes (Cat)₂[V₂O₂(O₂)₂(C₆H₆O₇)₂]·2H₂O (B) (Cat⁺=K⁺, NH₄ ⁺). Both classes of compounds were characterized analytically and spectroscopically. The X-ray structures of complexes A and B emphasize the exceptional stability of the dimeric rhombic unit V^V ₂O₂, which is retained upon H₂O₂ reaction, and the preserved mode of coordination of the citrate ligand as a doubly deprotonated moiety. In these complexes, typical six and eight coordination numbers were observed for the Na⁺ and K⁺ counter-ions, respectively. The variety of synthetic approaches leading to A, along with the stepwise and direct assembly and isolation of peroxo-compounds (B), denotes the significance of reaction pathways and intermediates in vanadium(III–V)–citrate synthetic chemistry. Hence, a systematic investigation of reactivity modes in aqueous vanadium–citrate systems emerges as a crucial tool for the establishment of chemical interconnectivity among low MW complex species, potentially participating in the intricate biodistribution of that metal ion in biological fluids.     

Synthesis, characterization and in vitro cytotoxicity of the first palladium(II) oxalato complexes involving adenine-based ligands

The first [Pd(Lⁿ)₂(ox)] xH₂O oxalato(ox) complexes involving 2-chloro-N6-(benzyl)-9-isopropyladenine (L¹; complex 1), 2-chloro-N6-(4-methoxybenzyl)-9-isopropyladenine (L²; 2), 2-chloro-N6-(2,3-dimethoxybenzyl)-9-isopropyladenine (L³; 3), 2-chloro-N6-(2,4-dimethoxybenzyl)-9-isopropyladenine (L⁴; 4), and 2-chloro-N6-(4-methylbenzyl)-9-isopropyladenine (L⁵; 5) have been synthesized by the reactions of potassium bis(oxalato)palladate(II) dihydrate, [K₂Pd(ox)₂]·2H₂O, with the mentioned organic compounds (H₂ox = oxalic acid; x = 0 for 1-3 and 5 or 2 for 4). Elemental analyses (C, H, N), FTIR, Raman and NMR (¹H, ¹³C, ¹⁵N) spectroscopies, conductivity measurements and thermal studies (thermogravimetric and differential thermal analyses, TG/DTA) have been used to characterize the prepared complexes. The molecular structures of [Pd(L²)₂(ox)] (2) and [Pd(L⁵)₂(ox)]·L⁵·Me₂CO (5·L⁵·Me₂CO) have been determined by a single crystal X-ray analysis. The geometry of these complexes is slightly distorted square-planar with two appropriate Lⁿ (n = 2 or 5) molecules mutually arranged in the head-to-head (2) or head-to-tail (5) orientation. The Lⁿ ligands are coordinated to the central Pd(II) ion via the N7 atoms. The same conclusions regarding the binding properties of L¹-L⁵ ligands can be made based on multinuclear NMR spectra. In vitro cytotoxicity of the complexes 1-5 has been evaluated against human chronic myelogenous leukaemia (K562) and human breast adenocarcinoma (MCF7) cancer cell lines. Significant cytotoxicity has been determined for the complexes 3 (IC₅₀ = 6.2 μM) and 5 (IC₅₀ = 6.8 μM) on the MCF7 cell line, which is even better than that found for the well-known and widely-used platinum-bearing antineoplastic drugs, i.e. oxaliplatin and cisplatin.     

Tris(3-hydroxypropyl)phosphine is superior to dithiothreitol for in vitro assessment of vitamin K 2,3-epoxide reductase activity

Use of the reductant dithiothreitol (DTT) as a substrate for measuring vitamin K 2,3-epoxide reductase (VKOR) activity in vitro has been reported to be problematic because it enables side reactions involving the vitamin K₁ 2,3-epoxide (K₁>O) substrate. Here we characterize specific problems when using DTT and show that tris(3-hydroxypropyl)phosphine (THPP) is a reliable alternative to DTT for in vitro assessment of VKOR enzymatic activity. In addition, the pH buffering compound imidazole was found to be problematic in enhancing DTT-dependent non-enzymatic side reactions. Using THPP and phosphate-based pH buffering, we measured apparent Michaelis–Menten constants of 1.20 μM for K₁>O and 260 μM for the active neutral form of THPP. The K_m value for K₁>O is in agreement with the value that we previously obtained using DTT (1.24 μM). Using THPP, we successfully eliminated non-enzymatic production of 3-hydroxyvitamin K₁ and its previously reported base-catalyzed conversion to K₁, both of which were shown to occur when DTT and imidazole are used as the reductant and pH buffer, respectively, in the in vitro VKOR assay. Accordingly, substitution of THPP for DTT in the in vitro VKOR assay will ensure more accurate enzymatic measurements and assessment of warfarin and other 4-hydroxycoumarin inhibition constants.     

Evaluation of in vitro cytotoxicity and hepatotoxicity of platinum(II) and palladium(II) oxalato complexes with adenine derivatives as carrier ligands

In vitro antitumour activity of the [Pt(ox)(L_n)₂] (1-7) and [Pd(ox)(L_n)₂] (8-14) oxalato (ox) complexes involving N6-benzyl-9-isopropyladenine-based N-donor carrier ligands (L_n) against ovarian carcinoma (A2780), cisplatin resistant ovarian carcinoma (A2780cis), malignant melanoma (G-361), lung carcinoma (A549), cervix epitheloid carcinoma (HeLa), breast adenocarcinoma (MCF7) and osteosarcoma (HOS) human cancer cell lines was studied. Some of the tested complexes were even several times more cytotoxic as compared with cisplatin employed as a positive control. The improved cytotoxic effect was demonstrated for the platinum(II) complexes 3 (IC₅₀ = 3.2 ± 1.0 μM and 3.2 ± 0.6 μM) and 5 (IC₅₀ = 4.0 ± 1.0 μM and 4.1 ± 1.4 μM) against A2780 and A2780cis, as compared with 11.5 ± 1.6 μM, and 30.3 ± 6.1 μM determined for cisplatin, respectively. The significant in vitro cytotoxicity against MCF7 (IC₅₀ = 8.2 ± 3.8 μM for 12) and A2780 (IC₅₀ = 5.4 ± 1.2 μM for 14) was evaluated for the palladium(II) oxalato complexes, which again exceeded cisplatin, whose IC₅₀ equalled 19.6 ± 4.3 μM against the MCF7 cells. Selected complexes were also screened for their in vitro cytotoxic effect in primary cultures of human hepatocytes and they were found to be non-hepatotoxic.     

Effect of environmental factors on survival and growth of quahog parasite unknown (QPX) in vitro

Quahog parasite unknown (QPX) is a protistan microorganism associated with mass mortalities of hard clams (Mercenaria mercenaria) along the northeastern coasts of the United States and maritime Canada. Because several studies indicate modulatory effects of prevailing environmental parameters on disease outbreaks, this study tested the effect of major environmental parameters (temperature, salinity and oxygen concentration; individually or combined) on QPX survival in artificial seawater and parasite growth in culture media in vitro. Three QPX isolates from two different geographic locations were compared. Results indicated that in vitro growth of QPX was optimal in standard culture medium at 34 ppt between 20 °C and 23 °C. Additionally, significant differences in temperature optima were observed for geographically distinct QPX isolates (p < 0.001) confirming previous studies suggesting the existence of different QPX strains (or ecotypes). When tested in seawater, QPX exhibited opposite trends with higher survival at 15 °C and 15 ppt. Results also demonstrated limited survival and growth of QPX under anoxic conditions. Additionally, results showed that the parasite is able to survive extreme temperatures (−12 °C to 32 °C) suggesting that QPX could overcome short periods of extreme conditions in the field. These results contribute to a better understanding of interactions between QPX and its environment, but potential impacts of environmental conditions on QPX disease development need further work as it also involves clam response to these factors.     

H2O2 induces rapid biophysical and permeability changes in the plasma membrane of Saccharomyces cerevisiae

In Saccharomyces cerevisiae, the diffusion rate of hydrogen peroxide (H₂O₂) through the plasma membrane decreases during adaptation to H₂O₂ by means of a mechanism that is still unknown. Here, evidence is presented that during adaptation to H₂O₂ the anisotropy of the plasma membrane increases. Adaptation to H₂O₂ was studied at several times (15min up to 90min) by applying the steady-state H₂O₂ delivery model. For wild-type cells, the steady-state fluorescence anisotropy increased after 30min, or 60min, when using 2-(9-anthroyloxy) stearic acid (2-AS), or diphenylhexatriene (DPH) membrane probe, respectively. Moreover, a 40% decrease in plasma membrane permeability to H₂O₂ was observed at 15min with a concomitant two-fold increase in catalase activity. Disruption of the ergosterol pathway, by knocking out either ERG3 or ERG6, prevents the changes in anisotropy during H₂O₂ adaptation. H₂O₂ diffusion through the plasma membrane in S. cerevisiae cells is not mediated by aquaporins since the H₂O₂ permeability constant is not altered in the presence of the aquaporin inhibitor mercuric chloride. Altogether, these results indicate that the regulation of the plasma membrane permeability towards H₂O₂ is mediated by modulation of the biophysical properties of the plasma membrane.     

Palladium(II) oxalato complexes involving N6-(benzyl)-9-isopropyladenine-based N-donor carrier ligands: Synthesis, general properties, H, C and N{H} NMR characterization and in vitro cytotoxicity

Reactions of potassium bis(oxalato)palladate dihydrate, K₂[Pd(ox)₂]·2H₂O, with two molar equivalents of N6-(benzyl)-9-isopropyladenine-based organic molecules (L_1-7), i.e. 2-chloro-N6-(2-methoxybenzyl)-9-isopropyladenine (L₁), 2-chloro-N6-(3-methoxybenzyl)-9-isopropyladenine (L₂), 2-chloro-N6-(3,5-dimethoxybenzyl)-9-isopropyladenine (L₃), 2-(1-ethyl-2-hydroxyethylamino)-N6-(benzyl)-9-isopropyladenine (L₄), 2-(1-ethyl-2-hydroxyethylamino)-N6-(2-methoxybenzyl)-9-isopropyladenine (L₅), 2-(1-ethyl-2-hydroxyethylamino)-N6-(3-methoxybenzyl)-9-isopropyladenine (L₆) and 2-(1-ethyl-2-hydroxyethylamino)-N6-(4-methoxybenzyl)-9-isopropyladenine (L₇), provided a series of seven palladium(II) oxalato (ox) complexes of the general formula [Pd(ox)(L_1-7)₂]·nH₂O (1-7; n = 0 for 4, 5 and 7, ¾ for 1 and 2, 1 for 6, and 3 for 3). The compounds were characterized by elemental analysis, IR, Raman, ¹H, ¹³C and ¹⁵N{¹H} NMR spectroscopy, ESI+ mass spectrometry, molar conductivity and TG/DTA thermal analysis. The geometry of [Pd(ox)(L₂)₂] (2) was optimized on the B3LYP/6-311G∗/LANL2DZ level of theory. The complexes 4-7 represent the first palladium(II) oxalato complexes with a PdN₂O₂ donor set, which involve highly potent purine-based cyclin-dependent kinase (CDK) inhibitors (L_4-7) as carrier N-donor ligands. The selected complexes 1, 3-5 and 7 were tested by an MTT assay for their in vitro cytotoxic activity against human osteosarcoma (HOS) cancer cell line. The highest activity was found for the complexes 5 (IC₅₀ = 34.9 μM) and 7 (IC₅₀ = 39.2 μM).     

Solution-mediated syntheses and characterizations of two new zincophosphites [C6H14N2]0.5[Zn(H2PO3)2] and [C4H12N2]0.5[(CH3)2NH2][Zn2(HPO3)3]

Two new zincophosphites [C₆H₁₄N₂]_0.5[Zn(H₂PO₃)₂] 1 and [C₄H₁₂N₂]_0.5[(CH₃)₂NH₂][Zn₂(HPO₃)₃] 2 have been solvothermally synthesized in mixed solvents of N,N-dimethylformamide (DMF) and 1,4-dioxane (DOA), respectively. Single-crystal X-ray diffraction analysis reveals that compound 1 exhibits a neutral inorganic chain formed by ZnO₄ and HPO₂(OH) units. Interestingly, the left- and right-handed hydrogen-bonded helical chains are alternately formed via the hydrogen-bonds between two adjacent chains. Compound 2 exhibits a layer structure with 4- and 12-MRs formed by ZnO₄ and HPO₃ units, in which two kinds of organic amine molecules both act as countercations to compensate the overall negative electrostatic charge of the anionic network.     

Synthesis and structure of a lead(II)-citrate: {Na(H2O)3}[Pb5(C6H5O7)3(C6H6O7)(H2O)3]·9.5H2O

The reaction of lead(II) nitrate with trisodium citrate Na₃(C₆H₅O₇) in a 1:22.5 ratio at pH 4.8 provides crystals of {Na(H₂O)₃}[Pb₅(H₂O)₃(C₆H₅O₇)₃(C₆H₆O₇)]·9.5H₂O (1). The structure of 1 is two-dimensional and exhibits five distinct Pb(II) sites and four different modes of citrate bonding. The five lead sites all display hemidirected coordination geometries, that is, irregular distribution of neighboring oxygen atoms resulting in obvious gaps in the coordination spheres. Consequently, the lead coordination geometries exhibit proximal bonding to a number of oxygen donors, as well as distal interactions with nearest neighbors. The coordination numbers vary from 8 to 10, with ‘5+3’, ‘5+4’, ‘6+4’ and ‘7+3’ coordination modes where the first number refers to the proximal ligands and the second to the distal set. The four crystallographically distinct citrate groups include three with deprotonated carboxylate groups (C₆H₅O₇)³⁻ and one with a single protonated carboxyl group (C₆H₆O₇)². The citrate ligands bridge 3, 5, 7 and 7 lead sites. Three of the citrate groups exhibit tridentate chelation coordination to a lead site through two carboxylate oxygen donors and the hydroxyl groups. One citrate group projects an uncoordinated -OH group and a pendant protonated carboxyl group into the interlamellar domain. This latter carboxyl group coordinates to a sodium cation, which exhibits five coordinate geometry defined by three aqua ligands and the carbonyl oxygen of the -CO₂H groups in the basal plane and a citrate -OH donor in the apical position.     

Rb2[B12(OH)12]·2H2O and Rb2[B12(OH)12]·2H2O2: Hydrate and perhydrolate of rubidium dodecahydroxo-closo-dodecaborate

The orthorhombically crystallizing salts Rb₂[B₁₂(OH)₁₂]·2H₂O (a = 1576.81(9), b = 813.08(5), c = 1245.32(7) pm) and Rb₂[B₁₂(OH)₁₂]·2H₂O₂ (a = 1616.54(9), b = 814.29(5), c = 1260.12(7) pm) could be prepared from Rb₂[B₁₂H₁₂] and hydrogen peroxide. Both crystal structures were determined by X-ray single crystal diffraction and refined in the space group Cmce. They are not isostructural to the other compounds containing icosahedral dodecahydroxo-closo-dodecaborate dianions [B₁₂(OH)₁₂]²⁻ and potassium, rubidium or cesium cations already known to literature, but both title compounds crystallize quasi-isotypically exhibiting Rb⁺ cations in 10-fold oxygen coordination. The hydrogen peroxide adduct (Rb₂[B₁₂(OH)₁₂]·2H₂O₂) is explosive on shock and heat, while the hydrate (Rb₂[B₁₂(OH)₁₂]·2H₂O) is not.     

Kinetic studies of the reduction of hexaaquacobalt(III) perchlorate by a cobaloxime, [Co(dmgBF2)2(H2O)2]

The reaction of with Co(dmgBF₂)₂(H₂O)₂ in 1.0 M HClO₄/LiClO₄ was found to be first-order in both reactants and the [H⁺] dependence of the second-order rate constant is given by k_2obs = b/[H⁺], b at 25 °C is 9.23 ± 0.14 × 10² s⁻¹. The [H⁺] dependence at lower temperatures shows some saturation effect that allowed an estimate of the hydrolysis constant for as K_a = 9.5 × 10⁻³ M at 10 and 15 °C. Marcus theory and the known self-exchange rate constant for Co(OH₂)₅OH^2+/+ were used to estimate an electron self-exchange rate constant of k₂₂ = 1.7 × 10⁻⁴ M⁻¹ s⁻¹ for .     

In silico and in vitro characterization of phospholipase A2 isoforms from soybean (Glycine max)

At the present, no secreted phospholipase A₂ (sPLA₂) from soybean (Glycine max) was investigated in detail. In this work we identified five sequences of putative secreted sPLA₂ from soybean after a BLAST search in G. max database. Sequence analysis showed a conserved PA2c domain bearing the Ca²⁺ binding loop and the active site motif. All the five mature proteins contain 12 cysteine residues, which are commonly conserved in plant sPLA₂s. We propose a phylogenetic tree based on sequence alignment of reported plant sPLA₂s including the novel enzymes from G. max. According to PLA₂ superfamily, two of G. max sPLA₂s are grouped as XIA and the rest of sequences as XIB, on the basis of differences found in their molecular weights and deviating sequences especially in the N- and C-terminal regions of the isoenzymes. Furthermore, we report the cloning, expression and purification of one of the putative isoenzyme denoted as GmsPLA₂-XIA-1. We demonstrate that this mature sPLA₂ of 114 residues had PLA₂ activity on Triton:phospholipid mixed micelles and determine the kinetic parameters for this system. We generate a model based on the known crystal structure of sPLA₂ from rice (isoform II), giving first insights into the three-dimensional structure of folded GmsPLA₂-XIA-1. Besides describing the spatial arrangement of highly conserved pair HIS-49/ASP-50 and the Ca⁺² loop domains, we propose the putative amino acids involved in the interfacial recognition surface. Additionally, molecular dynamics simulations indicate that calcium ion, besides its key function in the catalytic cycle, plays an important role in the overall stability of GmsPLA₂-XIA-1 structure.     

Synthetic and mechanistic studies on ruthenium dicarbonyl complexes containing PhP(CH2CH2CH2PCy2)2 (Cyttp) ligand

A synthetic and mechanistic study is reported on ligand substitution and other reactions of six-coordinate ruthenium(II) carbonyl complexes containing tridentate PhP(CH₂CH₂CH₂PCy₂)₂ (Cyttp). Carbonylation of cis-mer-Ru(OSO₂CF₃)₂(CO)(Cyttp) (1) affords [cis-mer-Ru(OSO₂CF₃)(CO)₂(Cyttp)]O₃SCF₃ (2(O₃SCF₃)) and, on longer reaction times, [cis-mer-Ru(solvent)(CO)₂(Cyttp)](O₃SCF₃)₂ (solvent = acetone, THF, methanol). 2(O₃SCF₃) reacts with each of NaF, LiCl, LiBr, NaI, and LiHBEt₃ to yield [cis-mer-RuX(CO)₂(Cyttp)]⁺ (X = F (3), Cl (4), Br (5), I (6), H (7)), isolated as 3-7(BPh₄). These conversions proceed with high stereospecificity to afford only a single isomer of the product that is assigned a structure in which the Ph group of Cyttp points toward the CO trans to X (anti when X = F, Cl, Br, or I; syn when X = H). Treatment of 2(O₃SCF₃) with NaOMe and CO generates the methoxycarbonyl complex [cis-mer-Ru(CO₂Me)(CO)₂(Cyttp)]⁺ (8), whereas addition of excess n-BuLi to 2(O₃SCF₃) in THF under CO affords mer-Ru(CO)₂(Cyttp) (9). The two ¹³C isotopomers [cis-mer-Ru(OSO₂CF₃)(CO)(¹³CO)(Cyttp)]O₃SCF₃ (2′(O₃SCF₃): ¹³CO trans to P_C; 2″(O₃SCF₃): ¹³CO cis to all P donors) were synthesized by appropriate adaptations of known transformations and used in mechanistic studies of reactions with each of LiHBEt₃, NaOMe/CO, and n-BuLi. Whereas LiHBEt₃ reacts with 2′(O₃SCF₃) and 2″(O₃SCF₃) to replace triflate by hydride without any scrambling of the carbonyl ligands, the corresponding reactions of NaOMe-CO are more complex. The methoxide combines with the CO cis to triflate in 2, and the resultant methoxycarbonyl ligand ends up positioned trans to the incoming CO in 8. A mechanism is proposed for this transformation. Finally, treatment of either 2′(O₃SCF₃) or 2″(O₃SCF₃) with an excess of n-BuLi leads to the formation of the same two ruthenium(0) isomers of mer-Ru(CO)(¹³CO)(Cyttp). These products represent, to our knowledge, the first example of a syn-anti pair of isomers of a five-coordinate metal complex.     

A new arylimido derivative of polyoxometalate (Bu4N)2[Mo6O17(NAr)2] [Ar = 2,6-(CH3)2C6H3]: Synthesis, structure and physicochemical properties

A novel bifunctionalized arylimido derivative of hexamolybdate, (Bu₄N)₂[Mo₆O₁₇(NAr)₂] [Ar = 2,6-(CH₃)₂C₆H₃] (1), in which the two 2,6-dimethylaniline groups are bounded to hexamolybdate at the cis positions, was synthesized by a facile reaction of α-octamolybdate with 2,6-dimethylaniline using DCC as a dehydration agent. The existence of strong non-typical C-H?O hydrogen bonds plays an important role in crystal structure stabilization of compound 1. The results of fluorescence spectra show that the formation of a covalent bond between 2,6-dimethylaniline molecule and hexamolybdate could efficiently quench the fluorescence intensity of 2,6-dimethylaniline molecule, with a fluorescence quencher efficiency of 87.7%. Thermal analysis results indicate that two substituted 2,6-(CH₃)₂C₆H₃ molecules bonding to the same cluster dissociated at different temperature, in well agreement with the different MoN bond length in compound 1. The electrochemical behavior of modified 1-CPE has been studied in detail. Compared with the conventional polyoxometalate (POM)-modified electrode, 1-CPE presents a merit of remarkable stability over 500 cycles due to the insolubility of the POM nanoparticles, which is especially important for practical applications.     

Platinum(IV) complexes with ethylenediamine-N,N′-diacetate diester (R2edda) ligands: Synthesis, characterization and in vitro antitumoral activity

The novel N,N-type bidentate ligand precursors, diethyl, dipropyl esters of ethylenediamine-N,N′-diacetic acid dihydrochloride (HOOCCH₂NHCH₂CH₂NHCH₂COOH · 2HCl, H₂edda · 2HCl), and the corresponding tetrachloroplatinum(IV) complexes, [PtCl₄(R₂edda)] · H₂O (ROOCCH₂NHCH₂CH₂NHCH₂COOR, R = Me, Et, n-Pr), were synthesized. The esters coordinated as bidentate ligands via both N donor atoms. The esters, as well as the complexes, have been characterized by infrared, ¹H and ¹³C NMR spectroscopy and elemental analysis. Solid state structures of both dimethyl and diethyl ester platinum(IV) complexes have been determined by X-ray crystallography. Quantum chemical calculations were performed in order to investigate diastereoselectivity in the formation of the platinum(IV) complexes. The in vitro cytotoxic evaluation of the investigated complexes in human tumor cell lines 1411HP, H12.1 (both testicular germ cell tumors), DLD-1 (colon carcinoma), 518A2 (melanoma), A549 (lung carcinoma) and liposarcoma showed a dose-dependent antiproliferative effect in all cell lines. Remarkably, the highest cytotoxic activity was observed in the cisplatin-resistant cell line 1411HP. In addition, at higher concentrations the treatment with these complexes led to the induction of apoptosis in all cell lines except for DLD-1.     

Synthesis and characterization of four cubical molybdenum(V) tetramers and their catalytic properties for the epoxidation of cis-cyclooctene using H2O2

Molybdenum tetramers: Mo₄(μ³-O)₄[μ-O₂P(CH₂Cl)₂]₄O₄ (1), Mo₄(μ³-O)₄(μ-O₂P(CH₂OH)₂)₄O₄ (2), Mo₄(μ³-O)₄[μ-O₂P(PhOMe)₂]₄O₄ (3), and Mo₄(μ³-O)₄[μ-O₂P(o-C₆H₄(CH₂)₂)]₄O₄ (4) have been synthesized and characterized by IR, UV-Vis, and ³¹P NMR spectroscopy. Molybdenum tetramers 1 and 4 along with the ligands L2A and L4 were structurally characterized by single crystal X-ray crystallography. An infinite 2D polymeric sheet was formed via inter and intra hydrogen bonds in the crystals of L2A. The crystals of L4 consist of infinite polymeric chains formed through hydrogen bonding. All molybdenum tetramers were tested as catalysts for the epoxidation of cis-cyclooctene in the presence of H₂O₂. Compounds 1 and 2 resulted in more than 80% epoxide after 24 hours at 70 °C, and displayed superior catalytic activities over compounds 3 and 4 under identical conditions. The superior catalytic activities of compounds 1 and 2 may be attributed to their better solubility in the ethanol/H₂O₂ system.